2Senftleben U,Cao Y,Xiao G,et al .Activation by IKK alpha of a second,evolutionary conserved,NF kappa B signaling pathway [J].Science,2001,293:1495-1499.
3Basak S,Shih VF,Hoffmann A.Generation and activation of multipledimeric transcription factors within the NF kappa B signalingsystem[J].Mol Cell Biol,2008,28:3139-3150.
5Gordon JW,Shaw JA,Kirshenbaum LA.Multiple facets of NF κBin the heart:to be or not to NF κB [J].Circ Res,2011,108(9):1122-1132.
6Pomerantz JL,Baltimore D.Two pathways to NF kappa B[J].Mol Cell,2002,10:693-695.
7Neumann M,Naumann M.Beyond I kappa Bs:alternative regulationof NF kappa B activity[J].FASEB J,2007,21:2642-2654.
8Kato Jr T,Delhase M,Hoffmann A,et al .CK2 is a C Terminal Ikappa B Kinase Responsible for NF kappa B activation duringthe UV response[J].Mol Cell,2003,12:829-839.
9Li JJ,Feng CH.Atherosclerosis is a more rational term for thepathological entity currently knowed as atherosclerosis [J].MedHypotheses,2004,63(1):100-102.
10Ross R.Atherosclerosis an inflammatory disease [J].N EnglMed,1999,340(2):115-126.
2Thorp E,Li Y,Bao L,et al.Brief report:increased apoptosis in advanced atherosclerotic lesions of Apoe-/-mice lacking macrophage Bcl-2[J].Arterioscler Thromb Vasc Biol,2009;29(2):169-72.
3Galkina E,Ley K.Immune and inflammatory mechanisms of atherosclerosis[J].Annu Rev Immunol,2009;27(1):165-97.
4Aukrust P,Otterdal K,Yndestad A,et al.The complex role of T-cell-based immunity in atherosclerosis[J].Curr Atheroscler Rep,2008;10(3):236-43.
5Methe H,Brunner S,Wiegand D,et al.Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes[J].J Am Coll Cardiol,2005;45(12):1939-45.
6Doran AC,Meller N,McNamara CA.Role of smooth muscle cells in the initiation and early progression of atherosclerosis[J].Arterioscler Thromb Vasc Biol,2008;28(5):812-9.
7Clarke MC,Littlewood TD,Figg N,et al.Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration[J].Circ Res,2008;102(12):1529-38.
8Wu G,Hu W,Shahsafaei A,et al.Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex[J].Circ Res,2009;104(4):550-8.
9Armstrong EJ,Morrow DA,Sabatine MS.Inflammatory biomarkers in acute coronary syndromes:part Ⅱ:acute-phase reactants and biomarkers of endothelial cell activation[J].Circulation,2006;113(7):e152-5.
10Wilson AM,Ryan MC,Boyle AJ.The novel role of C-reactive protein in cardiovascular disease:risk marker or pathogen[J].Int J Cardiol,2006;106(3):291-7.
